ArticleTurk psikiyatri dergisi = Turkish journal of psychiatry2025
The Role of Illness Representations and Metacognitive Beliefs in Mood in People with Type 2 Diabetes: A study from the COVID-19 Period.
Article in Turk psikiyatri dergisi = Turkish journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDiabetes poses a significant global health threat due to its increasing prevalence and associated comorbidities, straining healthcare systems worldwide. Depression and anxiety are frequent comorbidities in individuals with diabetes, and their underlying mechanisms have been a subject of research. This study investigated the influence of metacognitions and metacognitions about symptom control (MaSC) on depression and anxiety in people with type 2 diabetes (T2D), specifically examining their effects beyond illness representations.
methodConducted during the COVID-19 pandemic, this study involved 153 T2D patients. Participants completed the Hospital Anxiety and Depression Scale (HADS), Brief Illness Perception Questionnaire (B-IPQ), Metacognitions Questionnaire-30 (MCQ-30), Metacognitions about Symptom Control Scale-Revised (MaSCS-R), and the Protection Motivation Theory Scale for COVID-19 Preventive Behaviors.
resultsHierarchical regression analysis showed that after controlling for socio-demographic variables, fear of COVID-19, and illness representations, negative metacognitions about symptom control predicted 2% of anxiety and 4% of depression; metacognitions predicted 10% of anxiety and 9% of depression.
conclusionMetacognitions predicted both depression and anxiety, supporting the Self-Regulatory Executive Function (S-REF) model. Metacognitive therapy could be an alternative for managing emotional distress in T2D patients and may contribute to future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.